Eastern Biotech launches Newborn Screening Test

IEMs (inborn errors of metabolisms) prevent babies from 'processing' food properly, leading to an accumulation of toxic chemicals in the blood, which are harmful for their normal development. The tests detect abnormal levels of these chemicals shortly after the baby is born.

One of the best reasons to have your infant screened is because many rare disorders that manifest in children often mimic more common diseases making diagnosis difficult and challenging. Children may fall morbidly ill before a proper diagnosis is obtained. Using the results from IEMs screening, physicians have an advantage of recognizing specific illnesses prior to the onset of symptoms, thereby paving the way for early intervention.

The screening is performed on a small sample of blood obtained by pricking the baby's heel. The blood is allowed to dry on absorbent paper and sent to Eastern Biotech. Just a simple drop of blood taken at birth can help detect devastating metabolic disorders in infants.

"Metabolic disorders are not common, but they do occur, and are usually serious and often deadly," said Dr, Sanjida Ahmed, Director Research at Eastern Biotech. "The supplemental screening program allows us to identify these conditions soon after the birth and start the treatment before the babies suffer brain damage or other permanent disorders."

"We are pleased to offer this screening program in the Middle East," said Pankaj Sohaney, Manager of Eastern Biotech. The first time in Healthcare Industry Eastern Biotech is introducing Gift coupons for the test so that nearer & dearer of the new born can present this priceless gift which is required once in a life time. The newborn screening program "NBS" has two major benefits: first, it identifies the babies who need treatment as early as possible, and second, it provides peace of mind to the parents whose newborns are healthy."